Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Bioorganic & Medicinal Chemistry Letters
|
November 3, 2012
Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H₁ antagonists. Part II: optimising in vivo clearance
Mark Furber, Lilian Alcaraz, Christopher Luckhurst, et al.
Plos Neglected Tropical Diseases
|
February 22, 2017
Anti-trypanosomal activity of non-peptidic nitrile-based cysteine protease inhibitors
Antonio C B Burtoloso, Sérgio de Albuquerque, Mark Furber, et al.
Journal of Medicinal Chemistry
|
March 6, 2014
Cathepsin C inhibitors: property optimization and identification of a clinical candidate
Mark Furber, Anna-Karin Tiden, Philip Gardiner, et al.
Journal of Medicinal Chemistry
|
October 30, 2007
Discovery of potent and selective adamantane-based small-molecule P2X(7) receptor antagonists/interleukin-1beta inhibitors
Mark Furber, Lilian Alcaraz, Janice E Bent, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Bioorganic & Medicinal Chemistry Letters
|
November 3, 2012
Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H₁ antagonists. Part II: optimising in vivo clearance
Mark Furber, Lilian Alcaraz, Christopher Luckhurst, et al.
Plos Neglected Tropical Diseases
|
February 22, 2017
Anti-trypanosomal activity of non-peptidic nitrile-based cysteine protease inhibitors
Antonio C B Burtoloso, Sérgio de Albuquerque, Mark Furber, et al.
Journal of Medicinal Chemistry
|
March 6, 2014
Cathepsin C inhibitors: property optimization and identification of a clinical candidate
Mark Furber, Anna-Karin Tiden, Philip Gardiner, et al.
Journal of Medicinal Chemistry
|
October 30, 2007
Discovery of potent and selective adamantane-based small-molecule P2X(7) receptor antagonists/interleukin-1beta inhibitors
Mark Furber, Lilian Alcaraz, Janice E Bent, et al.
Page
of 2